Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients With Preexisting Renal Dysfunction Undergoing a Coronary Procedure

NCT00345501 is registered in ClinicalTrials.gov with Onassis Cardiac Surgery Centre as lead sponsor.

NCT NCT00345501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00345501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients With Preexisting Renal Dysfunction Undergoing a Coronary Procedure
Lead sponsor
Onassis Cardiac Surgery Centre
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2005
Completion date
July 31, 2007
Enrollment
208 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angioplasty, transluminal, percutaneous coronary, coronary angiography, renal insufficiency, chronic